48 related articles for article (PubMed ID: 26174590)
1. Rural-Urban Differences in Prostate-Specific Antigen (PSA) Screening and Its Outcomes in New Zealand.
Obertová Z; Hodgson F; Scott-Jones J; Brown C; Lawrenson R
J Rural Health; 2016; 32(1):56-62. PubMed ID: 26174590
[TBL] [Abstract][Full Text] [Related]
2. Prostate Cancer Incidence and Aggressiveness in Appalachia versus Non-Appalachia Populations in Pennsylvania by Urban-Rural Regions, 2004-2014.
McDonald AC; Wasserman E; Lengerich EJ; Raman JD; Geyer NR; Hohl RJ; Wang M
Cancer Epidemiol Biomarkers Prev; 2020 Jul; 29(7):1365-1373. PubMed ID: 32277006
[TBL] [Abstract][Full Text] [Related]
3. Rural-urban disparities in colorectal cancer survival and risk among men in Utah: a statewide population-based study.
Rogers CR; Blackburn BE; Huntington M; Curtin K; Thorpe RJ; Rowe K; Snyder J; Deshmukh V; Newman M; Fraser A; Smith K; Hashibe M
Cancer Causes Control; 2020 Mar; 31(3):241-253. PubMed ID: 32002718
[TBL] [Abstract][Full Text] [Related]
4. Determining the association of rurality and cardiovascular disease among prostate cancer survivors.
Nielsen S; O'Neil B; Chang CP; Mark B; Snyder J; Deshmukh V; Newman M; Date A; Galvao C; Henry NL; Lloyd S; Hashibe M
Urol Oncol; 2023 Oct; 41(10):429.e15-429.e23. PubMed ID: 37455231
[TBL] [Abstract][Full Text] [Related]
5. Cancer Screening among immigrants living in urban and regional Australia: results from the 45 and up study.
Weber MF; Chiew M; Feletto E; Kahn C; Sitas F; Webster L
Int J Environ Res Public Health; 2014 Aug; 11(8):8251-66. PubMed ID: 25153460
[TBL] [Abstract][Full Text] [Related]
6. A Latent Disease Model to Reduce Detection Bias in Cancer Risk Prediction Studies.
Aleshin-Guendel S; Lange J; Goodman P; Weiss NS; Etzioni R
Eval Health Prof; 2021 Mar; 44(1):42-49. PubMed ID: 33506704
[TBL] [Abstract][Full Text] [Related]
7. Determinants of receipt of prostate cancer screening among men living with HIV enrolled in an urban HIV Clinic in the United States over the period of 2000-2020.
Pirsl F; Keruly JC; Moore RD; Lau B; Joshu CE
Prev Med; 2024 May; 184():108000. PubMed ID: 38735585
[TBL] [Abstract][Full Text] [Related]
8. Adverse health outcomes among rural prostate cancer survivors: A population-based study.
Huang D; Chang CE; Newman M; Deshmukh V; Snyder J; Date A; Galvao C; Lloyd S; Henry NL; O'Neil B; Hashibe M
Cancer Epidemiol; 2023 Oct; 86():102430. PubMed ID: 37473579
[TBL] [Abstract][Full Text] [Related]
9. [No Differences in Testis Cancer Outcomes between urban and rural regions in the Canton of Berne].
Helnwein S; Hoch D; Beyer J
Praxis (Bern 1994); 2024 Jan; 113(1):12-14. PubMed ID: 38381104
[TBL] [Abstract][Full Text] [Related]
10. PSA screening - for whom and when?
Albers P
Asian J Androl; 2017 Sep; 21(1):3-5. PubMed ID: 28879867
[TBL] [Abstract][Full Text] [Related]
11. What are the factors that influence the delivery of smoking cessation advice in critical care?
Lang M; Waterworth S; O'Brien A
Nurs Crit Care; 2018 Sep; 23(5):237-244. PubMed ID: 26177914
[TBL] [Abstract][Full Text] [Related]
12. Suicidal ideation and behaviour.
Korczak DJ;
Paediatr Child Health; 2015; 20(5):257-64. PubMed ID: 26175563
[TBL] [Abstract][Full Text] [Related]
13. The Cancer Stories Project: narratives of encounters with cancer in Aotearoa, New Zealand.
Egan R; Llewellyn R; Wood S; Doherty J; Albert T; Walsh C; Atkinson K; Kerslake P
Psychooncology; 2016 Mar; 25(3):300-7. PubMed ID: 26211449
[TBL] [Abstract][Full Text] [Related]
14. Review article: systematic review of three key strategies designed to improve patient flow through the emergency department.
Elder E; Johnston AN; Crilly J
Emerg Med Australas; 2015 Oct; 27(5):394-404. PubMed ID: 26206428
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and safety of short-stay units in the emergency department: a systematic review.
Galipeau J; Pussegoda K; Stevens A; Brehaut JC; Curran J; Forster AJ; Tierney M; Kwok ES; Worthington JR; Campbell SG; Moher D
Acad Emerg Med; 2015 Aug; 22(8):893-907. PubMed ID: 26201285
[TBL] [Abstract][Full Text] [Related]
16. Cancer Screening Among Rural and Urban Clinics During COVID-19: A Multistate Qualitative Study.
Hanna K; Arredondo BL; Chavez MN; Geiss C; Hume E; Szalacha L; Christy SM; Vadaparampil S; Menon U; Islam J; Hong YR; Alishahi Tabriz A; Kue J; Turner K
JCO Oncol Pract; 2022 Jun; 18(6):e1045-e1055. PubMed ID: 35254884
[TBL] [Abstract][Full Text] [Related]
17. Urban-rural prostate cancer disparities in a regional state of Australia.
Foley GR; Blizzard CL; Stokes B; Skala M; Redwig F; Dickinson JL; FitzGerald LM
Sci Rep; 2022 Feb; 12(1):3022. PubMed ID: 35194109
[TBL] [Abstract][Full Text] [Related]
18. Assessment of factors associated with PSA level in prostate cancer cases and controls from three geographical regions.
Karunasinghe N; Minas TZ; Bao BY; Lee A; Wang A; Zhu S; Masters J; Goudie M; Huang SP; Jenkins FJ; Ferguson LR
Sci Rep; 2022 Jan; 12(1):55. PubMed ID: 34997089
[TBL] [Abstract][Full Text] [Related]
19. Attitudes of rural communities towards the use of technology for health purposes in New Zealand: a focus group study.
Babbage DR; van Kessel K; Terraschke A; Drown J; Elder H
BMJ Open; 2020 Jun; 10(6):e037892. PubMed ID: 32487583
[TBL] [Abstract][Full Text] [Related]
20. Geographical Variations in Prostate Cancer Outcomes: A Systematic Review of International Evidence.
Dasgupta P; Baade PD; Aitken JF; Ralph N; Chambers SK; Dunn J
Front Oncol; 2019; 9():238. PubMed ID: 31024842
[No Abstract] [Full Text] [Related]
[Next] [New Search]
